AKAP 9 Antibodies

Santa Cruz Biotechnology features a diverse variety of AKAP 9 monoclonal antibodies for research focused on A-kinase anchoring protein 9. AKAP 9 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AKAP 9 plays a crucial role in anchoring protein kinase A (PKA) to specific cellular compartments, thereby regulating various signaling pathways that influence cell growth, differentiation, and survival. The involvement of AKAP 9 in organizing signaling complexes makes it essential for maintaining cellular homeostasis and responding to extracellular signals. Dysregulation of AKAP 9 has been implicated in several diseases, including cancer, highlighting its importance as a target for therapeutic intervention. AKAP 9 monoclonal antibodies enable detailed investigation of cellular signaling mechanisms and their impact on disease progression. Researchers worldwide rely on AKAP 9 monoclonal antibodies to advance scientific understanding of cellular regulation and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support breakthrough discoveries in cell signaling research, contributing to the advancement of therapeutic strategies.